As Founder, Chairman & CEO of NanoBiotech Pharma, Inc., my mission is to tackle & reverse many chronic degenerative diseases. Studies show that our novel regenerative approaches are effective. After 28 years of Family Practice & Emergency Medicine, I retired from clinical practice to dedicate myself to my R&D. Our previous in-house research is well-established & we now conduct all of our research with established researchers at prominent institutions like NASA, Mayo Clinic, Cleveland Clinic, UCSF, Stanford & etc...
In 1996, I invented NanobacTX, a patented compound, shown in published clinical trials by Cardiologists & Radiologists to Regress coronary artery plaque volume as objectively documented via serial Coronary Artery Calcification (CAC) Scores, Eliminate angina symptoms, Improve functional status & Increase exercise tolerance...meaning that we are reversing heart disease. My 2nd development is Urobac for kidney stones, chronic prostatitis, BPH & PKD. The 3rd is RegenurEYES for Cataracts, Glaucoma & AMD Macular Degeneration. I also invented a sandwich-ELISA rapid diagnostic: NanobacTEST-U/A for Nanobacteria. (CE Approved in EU & Research-Only USA).
Our most recent and compelling R&D is in Alzheimer's Disease & Vascular Dementia with confirmatory clinical trials in the planning stage.....
Our research shows we are not just treating the symptoms, but rather reversing the underlying disease processes of many previously "untreatable" chronic diseases.
Cheers!
Gary
EMail: gmezo@nanobiotechpharma.com
Website: http://www.NanoBiotechPharma.com